Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05523687 · ClinicalTrials.gov registry record · Phase 1
AME Study of [14C]-PC14586 in Healthy Male Participants
A Phase 1 study of Healthy Male Volunteers, sponsored by PMV Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT05523687: Completed Phase 1 study of Healthy Male Volunteers, sponsored by PMV Pharmaceuticals.
NCT05523687 is a Phase 1 study of Healthy Male Volunteers that has completed, run by PMV Pharmaceuticals. The registered enrollment target is 8 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05523687, a Phase 1 study of Healthy Male Volunteers, has completed, sponsored by PMV Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess the PK and rates of elimination and mass balance of total radioactivity from \[14C\]-PC14586
Primary Outcome
Determine Cmax for PC14586 and PC16163 in plasma.
Conditions Studied
Interventions
- DRUG [14C]-PC14586
Study Locations (1)
Wisconsin
- Labcorp Clinical Research Unit Inc. - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2022-09-06 |
| Est. Completion | 2022-11-30 |
| Phase | Phase 1 |
What the finished NCT05523687 record still lists
NCT05523687 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Healthy Male Volunteers appearing as the primary indexed condition, and to 1 intervention - of which [14C]-PC14586 is the first listed.
NCT05523687 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05523687 about?
NCT05523687 is a clinical study titled "AME Study of [14C]-PC14586 in Healthy Male Participants". This study will assess the PK and rates of elimination and mass balance of total radioactivity from \[14C\]-PC14586
What is the current status of trial NCT05523687?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2022-09-06. Estimated completion is 2022-11-30.
What conditions does trial NCT05523687 study?
This clinical trial studies the following conditions: Healthy Male Volunteers.
What interventions are being tested in trial NCT05523687?
The interventions under investigation include: [14C]-PC14586 (DRUG).
Who is sponsoring clinical trial NCT05523687?
This trial is sponsored by PMV Pharmaceuticals, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05523687 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Male Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05523687's enrollment target sits among peer trials
8 1959th of 2000 higher than 29 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI